Piper Jaffray analyst Edward Tenthoff raised his price target on Regeneron Pharma (NASDAQ: REGN) to $484.00 (from $415.00) following results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE